Driver of non-small cell lung cancer, FGFR1, also in 23 percent of small cell lung cancer

(University of Colorado Denver) University of Colorado Cancer Center research presented at AACR 2015 shows that promising treatments in development for non-small cell lung cancer may be applicable to small cell lung cancer, as well.